Concepedia
Statistics
Publications
70
Citations
5.9K
H-Index
35
Active since
1984
Affiliations
Novartis (United States)(Current)
National Institute of Environmental Health Sciences
Eli Lilly (United States)
AbbVie (United States)
GlaxoSmithKline (United States)
Volker Fischer is an author at Novartis (United States) specializing in medicine, pharmacology, and biochemistry.
Top concepts
MedicinePharmacologyEngineeringBiochemistryDrug DiscoveryPharmacokineticsComputer ScienceOxidative StressMachine LearningData Science
Publications per year
1984–2021
THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVE
Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf et al. · Drug Metabolism and Disposition · 2003 · 781 citations
Cyclosporine metabolism in human liver: Identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs
Thomas Kronbach, Volker Fischer, Urs Meyer · Clinical Pharmacology & Therapeutics · 1988 · 540 citations
Cytochrome P-450 hPCN3, a Novel Cytochrome P-450 IIIA Gene Product That Is Differentially Expressed in Adult Human Liver
Toshifumi Aoyama, Saki Yamano, David J. Waxman et al. · Journal of Biological Chemistry · 1989 · 481 citations · Full text
The Conduct of In Vitro and In Vivo Drug‐Drug Interaction Studies: A PhRMA Perspective
Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf et al. · The Journal of Clinical Pharmacology · 2003 · 309 citations
Drug Interactions, Preclinical Drug Evaluation, Biochemistry +14
SE(3)-Transformers: 3D Roto-Translation Equivariant Attention Networks
Fabian B. Fuchs, Daniel E. Worrall, Volker Fischer et al. · arXiv (Cornell University) · 2020 · 223 citations · Full text
Geometric Learning, Engineering, Machine Learning +19
1–5 of 70